Spotlight Therapeutics: Guided by biotech vet, East Bay gene editing startup raises $36.5M
With the idea to correct gene mutations to cure diseases, the company now has raised close to $70 million and could be in the clinic with its first therapeutic in 2024
Read full article »
Spotlight Therapeutics is a California-based biotechnology company that develops non-viral gene-editing therapies to treat cancer and monogenic diseases.
Read more